Fountain Therapeutics
First-in-class therapies for diseases caused by aging
- Headquarters
- San Francisco Bay Area, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- fountaintx.com
- Last Round
- Extension RoundNov 2021
About
Fountain Therapeutics is a clinical-stage biopharmaceutical company discovering and developing first-in-class therapies for diseases and conditions caused by aging. The company's AI-driven biology platform identifies targets connecting aging biology to chronic degenerative diseases, with lead programs in skin atrophy and sarcopenia. Fountain is backed by Khosla Ventures, Lilly, Nan Fung Life Sciences, and Alexandria Venture Investments.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account